Sign in
4

Changes in Ownership

Theriva Biologics, Inc. Filed Acc 0001104659-23-018901

CEO and CFO bought 25,000 shares at $1.04 ($26,075)

From the SEC's structured data for this filing

Trades in this filing

SHALLCROSS STEVEN A · CEO and CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-10 Purchase : show line 1 in the form +25,000 $1.04 $26,075 210,000 D
Open-market purchases · 25,000 sh · avg $1.04 · $26,075
Loading xslF345X03/tm236426-1_4.xml…